X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Drug prices A third of employers this year are evaluating formulary strategies within their plan to either incentivize or require the use of lower-cost biosimilars when available. (Photo: Shutterstock)

Pretty much any action is worth trying if it can help curb the cost of health care for both employers and their workers, according to Willis Towers Watson’s 24th annual Best Practices in Health Care Employer Survey.

Katie Kuehner-Hebert

Katie Kuehner-Hebert is a freelance writer based in Running Springs, Calif. She has more than three decades of journalism experience, with particular expertise in employee benefits and other human resource topics.

More from this author

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.